Charles River Laboratories (CRL) Tops Q3 EPS by 12c, Updates Guidance
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $186.60 +2.78%
EPS Growth %: -12.5%
Financial Fact:
Loss from discontinued operations, net of tax: 342K
Today's EPS Names:
CRWS, MEI, PODC, More
EPS Growth %: -12.5%
Financial Fact:
Loss from discontinued operations, net of tax: 342K
Today's EPS Names:
CRWS, MEI, PODC, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q3 EPS of $2.70, $0.12 better than the analyst estimate of $2.58. Revenue for the quarter came in at $895.9 million versus the consensus estimate of $908.19 million.
GUIDANCE:
Charles River Laboratories sees FY2021 EPS of $10.20-$10.30, versus the consensus of $10.25.
- Revenue growth, reported 19.5% – 20.5
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Stifel Canada Starts BlackBerry (BB) at Buy
- Cerebras Q1 EPS miss sends shares down 9% after-hours
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
